Presenting laboratory characteristics of 97 iTTP patient episodes
| Parameters . | Values* . |
|---|---|
| White blood cells, ×109/L | 10.3 (8.4-13.3) |
| Hemoglobin, g/dL | 8.8 (7.5-9.6) |
| Hematocrit, % | 25 (22-28) |
| Platelet count, ×109/L | 14 (10-21.4) |
| Lactate dehydrogenase, U/L | 905 (559.5-1,363) |
| Creatinine, mg/dL | 1.2 (0.9-1.8) |
| Prothrombin time, s | 14.6 (14.1-15.5) |
| Partial thromboplastin time, s | 30 (27-34) |
| Fibrinogen, mg/dL | 415 (327-494) |
| D-dimer, ng/mL | 1,869 (979.5-3973.5) |
| ADAMTS13 activity, U/dL | 2.8 (0.6-4.9) |
| ADAMTS13 antigen, ng/mL | 54.7 (27.9-105.4) |
| ADAMTS13 inhibitor, BU | 1.6 (0.6-3.4) |
| Anti-ADAMTS13 IgG, IU/mL | 4368.5 (2717.1-7565.7) |
| Parameters . | Values* . |
|---|---|
| White blood cells, ×109/L | 10.3 (8.4-13.3) |
| Hemoglobin, g/dL | 8.8 (7.5-9.6) |
| Hematocrit, % | 25 (22-28) |
| Platelet count, ×109/L | 14 (10-21.4) |
| Lactate dehydrogenase, U/L | 905 (559.5-1,363) |
| Creatinine, mg/dL | 1.2 (0.9-1.8) |
| Prothrombin time, s | 14.6 (14.1-15.5) |
| Partial thromboplastin time, s | 30 (27-34) |
| Fibrinogen, mg/dL | 415 (327-494) |
| D-dimer, ng/mL | 1,869 (979.5-3973.5) |
| ADAMTS13 activity, U/dL | 2.8 (0.6-4.9) |
| ADAMTS13 antigen, ng/mL | 54.7 (27.9-105.4) |
| ADAMTS13 inhibitor, BU | 1.6 (0.6-3.4) |
| Anti-ADAMTS13 IgG, IU/mL | 4368.5 (2717.1-7565.7) |
All values are expressed as the median (IQR).